Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/evhqCfbwnsfKdNjlJkUK

May 10, 2013News for medical technology professionals

  Top Story 
 
  • NP Medical wins FDA nod for infusion therapy device
    The FDA has cleared NP Medical to market its nPulse Valve Platform, a needle-free connector used during infusion therapy. The device has a dual seal to prevent the introduction of bacteria and provide leak protection in high-pressure and arterial applications. MedGadget.com (5/8) LinkedInFacebookTwitterEmail this Story
Streamline Combination Product Development
This complimentary white paper from Novella Clinical explores combination product regulatory strategies - from classification to market clearance. Combination product sponsors can avoid numerous regulatory hurdles by downloading this white paper now: Clarifying the Regulatory Road for Combination Products.
  Business & Market Trends 
  • Rainbow Medical reportedly lands $10M investment from Sony
    Sony reportedly has pumped $10 million into Rainbow Medical, an Israeli firm that invests in medical-device manufacturers. Rainbow Medical, which specializes in devices that involve electrical stimulation of the body, has also received backing from Abbott Laboratories and Medtronic in the past. Sony's CEO has said the company wants to expand its medical operations, and the investment will allow Sony to ask for customized products. Globes (Israel) (5/9) LinkedInFacebookTwitterEmail this Story
  International Developments 
  • St. Jude's next-gen heart defibrillators gain CE mark
    St. Jude Medical has earned the CE mark in Europe to market its Ellipse and SJM Assura implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The devices automatically adjust voltage in the event of an electrical short and help reduce risk for lead abrasion. RTT News (5/8) LinkedInFacebookTwitterEmail this Story
  Science & Health 
  • Boston Scientific device outperforms warfarin in atrial fibrillation study
    Boston Scientific's Watchman device proved more effective and safer in treating patients with atrial fibrillation than the anti-coagulant drug warfarin, according to a 707-participant study. The study showed Watchman was superior to warfarin "for the combined endpoint of all stroke, cardiovascular or unexplained death and systemic embolism," the company said in a release. MassDevice.com (Boston) (5/9) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 
  • New lightweight exoskeletons get closer to market
    Among a new generation of lightweight powered exoskeletons is the 27-pound Indego, which can be fitted together from pieces carried in a backpack. The device, which allows paraplegics with spinal injuries or diseases such as cerebral palsy to walk independently, was developed by Vanderbilt University and demonstrated recently at the American Spinal Injury Association meeting in Chicago. National Public Radio/The Associated Press (5/9) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

Interested in learning more about advertising with SmartBrief? Click here for detailed industry information and media kits. 

  Government & Regulatory 
  • FDA OKs Combat Medical's device to stem heavy bleeding
    Combat Medical Systems has been cleared by the FDA to market its Combat Ready Clamp for use in treating junctional hemorrhage on the battlefield or any other emergency situation. The viselike device, which can be applied in less than 60 seconds, proves useful when manual pressure isn't enough and standard tourniquets don't work. MedGadget.com (5/9) LinkedInFacebookTwitterEmail this Story
AdvaMed News 
  • 510(k) Submissions Workshop
    Monday, Oct. 21 – Tuesday, Oct. 22
    Sheraton Crystal City, Arlington, Va.
    Join quality and regulatory professionals at this interactive 510(k) workshop. Industry experts and key personnel from the FDA CDRH and CBER 510(k) staff will inform you in detail on: current FDA updates to the 510(k) process--Refuse to Accept Policy for 510(k)s; a step-by-step walk-through of the 510(k) regulatory guidelines; 510(k) practical steps and strategic considerations for determining a product's regulatory route to market; planning and assembling a 510(k) submission; 510(k) post-clearance issues; eCopy program for medical device submissions; and more. Visit MTLI online to learn more. LinkedInFacebookTwitterEmail this Story
  • Follow AdvaMed on Google+
    Stay updated on industry news and educational opportunities -- receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Network with industry experts and leaders. Our Google+ page is interactive and incorporates updates from key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Follow us on Google+. LinkedInFacebookTwitterEmail this Story
 
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

 
Position TitleCompany NameLocation
Regulatory Affairs SpecialistSorin Group CanadaBurnaby, Canada
Assistant General Counsel, Regulatory Kimberly-Clark Roswell, GA
Compliance Consultant 2DJO GlobalVista, CA
Senior Software QA EngineerIRIS International, Inc.Chatsworth, CA
Principal Systems Engineer IRIS International, IncChatsworth, CA
Director, Regulatory Affairs - Critical Care - 002477Edwards LifesciencesIrvine, CA
Director of Medical Management for Delaware Physicians CareAetnaNewark, DE
Manager, ComplianceSmith & NephewMemphis, TN
Principal Scientist Wound CareHollister IncorporatedLibertyville, IL
Click here to view more job listings.

  SmartQuote 
Optimism is essential to achievement and it is also the foundation of courage and true progress."
--Nicholas Murray Butler,
American diplomat and educator


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information